Sanofi SA

Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-eligible newly diagnosed multiple myeloma

22 Jun 2025 22:00:00 By Nasdaq GlobeNewswire

Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid

19 Jun 2025 22:00:00 By Nasdaq GlobeNewswire

Press release: Sanofi successfully prices €1.5 billion bond issue

17 Jun 2025 04:40:00 By Nasdaq GlobeNewswire

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study

15 Jun 2025 08:22:00 By Nasdaq GlobeNewswire

Sanofi: Information concerning the total number of voting rights and shares - May 2025

09 Jun 2025 14:09:49 By Nasdaq GlobeNewswire

Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season

08 Jun 2025 22:00:00 By Nasdaq GlobeNewswire

Press release: Sanofi Launches 2025 Global Employee Stock Purchase Plan

05 Jun 2025 01:00:00 By Nasdaq GlobeNewswire

Press Release: ASCO: new Sarclisa data support subcutaneous administration with on-body injector

03 Jun 2025 05:26:33 By Nasdaq GlobeNewswire

Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease

02 Jun 2025 22:00:00 By Nasdaq GlobeNewswire

Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology

01 Jun 2025 22:00:00 By Nasdaq GlobeNewswire

Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology

01 Jun 2025 22:00:00 By Nasdaq GlobeNewswire

Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies

29 May 2025 22:00:00 By Nasdaq GlobeNewswire

Press Release: Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs

29 May 2025 05:30:00 By Nasdaq GlobeNewswire

Press Release: Sanofi completes acquisition of DR-0201

26 May 2025 22:00:00 By Nasdaq GlobeNewswire

Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline

21 May 2025 16:15:21 By Nasdaq GlobeNewswire

Sanofi: Information concerning the total number of voting rights and shares - April 2025

15 May 2025 10:06:42 By Nasdaq GlobeNewswire

Sanofi: Information concerning the total number of voting rights and shares - March 2025

02 May 2025 09:00:00 By Nasdaq GlobeNewswire

Press Release: Annual General Meeting of April 30, 2025

30 Apr 2025 09:46:28 By Nasdaq GlobeNewswire

Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader

30 Apr 2025 04:00:00 By Nasdaq GlobeNewswire

Press Release: When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race

29 Apr 2025 04:00:00 By Nasdaq GlobeNewswire